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Several syndromes characterized by defects in cardiovascular and craniofacial development are associated with a hemizygous deletion of
chromosome 22q11 in humans and involve defects in pharyngeal arch and neural crest cell development. Recent efforts have focused on
identifying 22q11 deletion syndrome modifying loci. In this study, we show that mouse embryos deficient for Gbx2 display aberrant neural
crest cell patterning and defects in pharyngeal arch-derived structures. Gbx2/ embryos exhibit cardiovascular defects associated with
aberrant development of the fourth pharyngeal arch arteries including interrupted aortic arch type B, right aortic arch, and retroesophageal
right subclavian artery. Other developmental abnormalities include overriding aorta, ventricular septal defects, cranial nerve, and craniofacial
skeletal patterning defects. Recently, Fgf8 has been proposed as a candidate modifier for 22q11 deletion syndromes. Here, we demonstrate
that Fgf8 and Gbx2 expression overlaps in regions of the developing pharyngeal arches and that they interact genetically during pharyngeal
arch and cardiovascular development.
D 2005 Elsevier Inc. All rights reserved.Keywords: Cardiovascular; 22q11 deletion syndrome; Pharyngeal arches; Pharyngeal arch arteries; Neural crest; Gbx2; Fgf8; DiGeorge syndromeIntroduction
Neural crest cells (NCCs) comprise a population of
multipotent cells that migrate from the region between the
dorsal neural tube and the surface ectoderm to populate
various developing structures throughout the vertebrate
embryo. NCCs contribute significantly to craniofacial and
cardiovascular development by populating and migrating
through the pharyngeal arches. Pharyngeal arches are
bilaterally symmetric structures that give rise to musculo-
skeletal elements of the head and neck rostrally and support
the differentiation of vascular structures within the arches
during early development caudally. Surface ectoderm covers
core mesenchymal cells, derived from paraxial mesoderm,
and pharyngeal endoderm lines the inner region of the
arches. Ecto-mesenchymal NCCs migrate into the arches0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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E-mail address: meyer031@mc.duke.edu (E.N. Meyers).and contribute to the non-core mesenchyme. A specific
population of NCCs, termed cardiac neural crest, populate
the third, fourth, and sixth pharyngeal arches (Kirby and
Waldo, 1990; Kirby et al., 1983; Jiang et al., 2000). Classic
ablation studies in chick that removed this population of
neural crest resulted in cardiovascular patterning defects
including outflow tract septation defects and abnormal
pharyngeal arch artery (PAA) patterning (Kirby et al.,
1983, 1985). These experiments illustrated the importance
of cardiac neural crest cells and suggested that aberrant
differentiation and/or development of this population of
cells may be a significant factor in the manifestation of
congenital heart defects (CHDs) (reviewed in Hutson and
Kirby, 2003).
CHDs are among the most common birth defects
observed in newborns. A number of syndromes, including
DiGeorge and Velocardiofacial syndrome, are associated
with hemizygous deletion of chromosome 22q11 and occur
with a frequency of ¨1:4000. Such syndromes, collectively
termed 22q11 deletion syndromes, are characterized by a284 (2005) 233 – 245
N.A. Byrd, E.N. Meyers / Developmental Biology 284 (2005) 233–245234wide array of defects stemming from aberrant development
of the pharyngeal apparatus including defects in PAA
remodeling, outflow tract and intracardiac septation defects,
as well as thymic, parathyroid, and craniofacial defects
(reviewed in Baldini, 2002). Approximately 90% of
individuals presenting with DiGeorge syndrome are hap-
loinsufficient for the 22q11 deletion (Carey et al., 1992;
Driscoll et al., 1993).
Tbx1, a T-box containing transcription factor, has been
identified as one candidate for 22q11 deletion syndromes
(Jerome and Papaioannou, 2001; Lindsay et al., 2001;
Merscher et al., 2001). Tbx1 mRNA is expressed in the
pharyngeal arches and loss of function mutants recapitulate
defects associated with 22q11 deletion syndromes (Jerome
and Papaioannou, 2001; Lindsay et al., 2001; Vitelli et al.,
2002a). Recently, mutations in the Tbx1 gene have been
identified in DiGeorge syndrome patients without the
classical deletion (Yagi et al., 2003).
Recent studies have placed Fgf8 in the Tbx1 pathway
(Vitelli et al., 2002b).Fgf8mRNA is expressed in pharyngeal
arch endoderm and ectoderm during PAA and cardiovascular
development in the mouse embryo (Crossley and Martin,
1995). The importance of FGF8 signaling to adjacent tissues
for the survival, patterning, and differentiation of the
pharyngeal arches has been well established (Trumpp et al.,
1999; Abu-Issa et al., 2002; Frank et al., 2002; Macatee et al.,
2003; Brown et al., 2004). Deletion of Fgf8 in the surface
ectoderm of the first pharyngeal arch results in death of the
neural crest population, ultimately leading to the loss of
derivates from the first arch (Trumpp et al., 1999). Deletion of
Fgf8 from all arch ectoderm and NCCs results in specific
PAA defects but not outflow tract defects (Macatee et al.,
2003), whereas deletion of Fgf8 in Tbx1-expressing cells
results in outflow tract defects (Brown et al., 2004). Mice
mutant for a hypomorphic allele of Fgf8 (Fgf8neo/) have
decreased Fgf8 mRNA in both the surface ectoderm and
pharyngeal endoderm and exhibit increased cell death in a
number of cell types in all arches, including NCCs (Meyers et
al., 1998; Abu-Issa et al., 2002; Frank et al., 2002). Fgf8neo/
mice exhibit defects in cardiac outflow tract and ventricular
septation as well as hypoplasia/aplasia of the third, fourth,
and sixth PAAs (Abu-Issa et al., 2002; Frank et al., 2002).
Gbx2 encodes a homeobox-containing transcription
factor necessary for the specification of the mid-hindbrain
organizer in mice and other vertebrates (Wassarman et al.,
1997; Martinez, 2001; Rhinn and Brand, 2001). Gbx2
mRNA is expressed in a zone caudal to the midbrain and is
coexpressed in this region with Fgf8 (Wassarman et al.,
1997). Gbx2 homozygous null mutant mice (Gbx2/),
generated by deleting the homeobox DNA binding domain,
die shortly after birth with forebrain and cerebellar defects
(Wassarman et al., 1997). Subsequent studies of Gbx2
function in vertebrates have focused primarily on the
development and patterning of isthmic organizer. In mouse
and chick, experiments have demonstrated the ability of
FGF8 protein application and misexpression to ectopicallyactivate Gbx2 expression in brain explants and endogenous
tissue, respectively, suggesting that FGF8 may exert some
of its effect through Gbx2 regulation during induction of the
mid–hindbrain organizer (Garda et al., 2001; Liu and
Joyner, 2001; Liu et al., 1999; Sato et al., 2001). Like
Fgf8, Gbx2 expression is also detected in the developing
pharyngeal arches of the mouse embryo between embryonic
days 8.5 and 10.5 (Wassarman et al., 1997; Waters et al.,
2003). Gbx2 expression in the pharyngeal arches has also
been detected in chick (Niss and Leutz, 1998; Shamim and
Mason, 1998) and zebrafish (Su and Meng, 2002; Rhinn et
al., 2003), yet its role in this region remains unexamined.
Here, we present a detailed analysis of cardiovascular and
pharyngeal arch-related defects associated with the loss of
Gbx2 gene function in the mouse. We demonstrate that,
similar to Fgf8 mutants, a percentage of Gbx2 mutant
embryos exhibit several of the characteristic phenotypes
associated with 22q11 deletion syndromes. Additionally, we
provide evidence that Fgf8 and Gbx2 interact genetically
during cardiovascular and pharyngeal arch development.
These findings suggest Gbx2 as a candidate in the pathology
of human congenital heart defects and in particular, as a
modifying locus for 22q11 deletion syndromes.Materials and methods
Generation, breeding, and genotyping
Generation of the Gbx2 mutant allele (Gbx2tm1Mrt) has
been previously described (Wassarman et al., 1997).
Embryonic day (E) 0.5 was defined as noon the day the
vaginal plug was detected. Gbx2 mutants were identified by
genotyping extra-embryonic yolk sac DNA as described
(Wassarman et al., 1997).
For the cardiovascular and pharyngeal arch developmen-
tal analysis, Gbx2 heterozygous breeding males and females
were backcrossed for more than six generations and
maintained on a C57Bl6 genetic background. Generation
of Fgf8+/D2,3 (Fgf8tm1.4Mrt) referred to as Fgf8+/ hereafter)
embryos has been previously described (Meyers et al.,
1998) and were maintained on a C57Bl6 background. Male
mice heterozygous for both Fgf8 and Gbx2 were mated to
Gbx2+/ females to produce progeny for analysis. Embryos
were genotyped for Gbx2 (as above) and for presence of the
Fgf8D 2,3 allele (Meyers et al., 1998).
In situ hybridization, immunohistochemistry, ink injections
Wholemount mRNA in situ hybridization was carried out
as described (Neubuser et al., 1997) using digoxygenin-
labeled probes generated from linearized plasmids. Results
were replicated at least 3 times in both mutant and wildtype
embryos treated identically.
Wholemount immunohistochemistry was performed as
follows: embryos were dissected at E10.5 and fixed over-
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rinsed several times in PBS, dehydrated through a stepwise
methanol gradient and then bleached in 3% H2O2 for 10
min to quench endogenous peroxidase activity. Embryos
were then rehydrated and preblocked 3% evaporated milk
powder, 0.1% Triton X-100/PBT on a rocker for 2 h at RT.
Primary antibody was added at the following dilutions in
blocking solution and incubated overnight at 4-C. Neuro-
filament 2H3 at 1:3 and Ap2a 3B5 concentrated antibody
at 1:200 [Developmental Studies Hybridoma Bank
(DSHB)]. Embryos were washed for several hours and
incubated with secondary antibody: goat anti-mouse HRP
conjugate at 1:500 and goat anti-mouse Cy3 (Jackson
ImmunoResearch Laboratories) at 1:500 in blocking
solution, respectively. Embryos were then washed and
developed with DAB tablets when applicable (Sigma) in
PBT.
Section immunohistochemistry was performed on
embryos cryosectioned at 12 Am and dried on a heat block
for 30 min. Sections were then rinsed briefly with PBT and
preblocked with 3% evaporated milk powder, 0.1% Triton
X-100/PBT at room temperature for 1 h. Sections were
incubated with primary antibodies in blocking solution o/n
at 4-C at the following concentrations: AP2a supernatant
(3B5, DSHB) 1:4, a SMA (1A4, Sigma) 1:500, PECAM
(Mec13.3, Pharmingen) 1:500. Sections were then rinsed 3
times 10V with blocking solution and incubated with the
appropriate secondary antibodies for 1.5 h at room temper-
ature. Following incubation, sections were washed 3 times
10V, counterstained with the fluorescent nuclear marker
Syto13 (Molecular Probes) for 5V, rinsed aggressively with
PBT, and coverslipped with Fluorosave (Calbiochem).
Images were captured with a Zeiss Axioplan II.
Pharyngeal arch artery development was visualized
during early development by intracardiac injection of India
ink just after dissection using a pulled pasteur pipette. Post-
injection, embryos were fixed in 4% PFA o/n, rinsed in PBT,
dehydrated through a MeOH gradient, and cleared in BABB
for visualization.
Histology
Embryos were dehydrated through a graded methanol
series for ¨15 min per concentration (100% MeOH twice)
and cleared in toluene. Cleared embryos were then
incubated in paraffin overnight allowing for several wax
changes to remove all traces of toluene. 8-Am sections were
counterstained with hematoxylin and eosin and coverslipped
using Cytoseal (Richard-Allan Scientific).
Images were captured with a Leica DFC320 digital
camera mounted on a Leica MZ12 dissecting scope.
Confocal microscopy
Confocal microscopy was performed on a Zeiss LSM
510 META. Images were prepared in Adobe Photoshop v.7.Control and mutant images were treated identically when
adjusted in Photoshop.Results
Perinatal Gbx2/ embryos display cardiovascular defects
Previous reports show that Gbx2 homozygous null
(Gbx2/) embryos exhibit cerebellar defects and die soon
after birth (Wassarman et al., 1997). We detected cyanotic
mutant pups at birth suggesting that neonatal lethality may
be attributable to cardiovascular defects. To test this
hypothesis, we performed dissections in near-term (E16.5–
E18.5) mutant and wildtype (WT) littermate embryos to
assess gross morphology of the cardiovascular system.
Approximately 39% of Gbx2 mutants (n = 19 of 49)
generated on a C57Bl6 genetic background exhibit cardio-
vascular defects, whereas no control (Gbx2+/, n = 72;
Gbx2+/+, n = 44) littermates displayed cardiovascular
abnormalities. AllGbx2 mutants displayed cerebellar defects
as described previously (Wassarman et al., 1997). By
morphological analysis, the observed cardiovascular defects
are primarily associated with the development and remodel-
ing of the fourth PAAs, which are infrequently accompanied
with a sixth PAA defect. In wildtype embryos (Fig. 1A), the
left fourth PAA forms the aortic arch and the right fourth
PAA forms the base of the right subclavian artery (brachio-
cephalic artery). The left sixth PAA forms the ductus
arteriosus, and the right sixth PAA regresses, as does the
right descending aorta. Gbx2/ arch artery defects include
interrupted aortic arch type B, whereby the segment between
the left common carotid artery and left subclavian artery is
absent (IAA-B, 26%, Fig. 1B), right aortic arch with a right
ductus arteriosus and persistence of the right descending
aorta (RAA, 37%, Fig. 1C), and retroesophageal right
subclavian artery (RE-RSA, 21%, Fig. 1D and Table 1).
These defects represent the predominant failure of the right
and left fourth PAAs to form their respective arteries, as well
as the occasional associated loss of the left sixth PAA and
persistence of the right sixth PAA and descending aorta.
Defects are not limited to the remodeling of the PAAs.
Normally, the ascending aorta arises from the left ventricle
and the pulmonary trunk stems from the right ventricle.
Conal–truncal defects, including double outlet right ven-
tricle (DORV) and overriding aorta (note position of aorta
relative to ventricular septum in Fig. 1F vs. Fig. 1E)
comprised a portion of Gbx2 mutants with cardiac-related
defects (¨16%—see Table 1).
To investigate whether intracardiac defects accompanied
the observed arterial remodeling defects and/or conal–
truncal defects, we performed histological analysis of near-
term hearts in control (n = 3) and Gbx2 (n = 5) mutant
littermates. Histological analysis of Gbx2 mutant hearts
revealed the presence of a membraneous ventricular septal
defect (VSD) (Fig. 1F, arrowhead). VSDs in mutant hearts
Fig. 1. Near-term defects in Gbx2 mutant hearts. Panels A–D show gross morphology of a wildtype heart (A) compared to a variety of arch artery defects in
Gbx2 mutants (B–D). Schematics illustrating the specific arterial elements and defects are shown directly adjacent to respective photos. (A) Wildtype
configuration with normal regression of right sixth PAA (R6). (B) Interrupted aortic arch type B whereby the left fourth PAA (L4) is absent as well as the right
brachiocephalic artery (R4). (C) Right-sided aortic arch with aberrant right subclavian resulting from the combined loss of the R4, L4, and L6 arterial segments.
Abnormal persistence of the R6 artery is present. (D) Retroesophageal right subclavian artery, which abnormally arises from the descending aorta. This results
from the absence of the R4 artery. Gbx2 mutant heart (F) with conal– truncal defect (overriding aorta) and a ventricular septal defect (arrowhead) compared to
wildtype (E). Note the aorta (Ao) sitting over the septum and part of the right ventricle in panel F compared to panel E. RS—right subclavian, RCC—right
common carotid, LCC—left common carotid, LS—left subclavian, R4—right fourth arch artery, L4—left fourth arch artery, R6—right sixth arch artery, L6—
left sixth arch artery, Ao—aorta, Pa—pulmonary artery, RV—right ventricle, LV—left ventricle, LSVC—left superior vena cava, RSVC—right superior vena
cava.
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aorta or DORV, n = 2), whereas no septal defects were
observed in hearts with isolated arterial remodeling defects
(IAA, RAA, n = 3). These observations demonstrate a role
for Gbx2 gene function during the development and
remodeling of the fourth PAAs and for proper alignment
of the conus.
Arterial development is defective in the presence of normal
pharyngeal arch segmentation in Gbx2 mutants
The adult asymmetric configuration of pharyngeal arch-
derived arteries originates from an initially bilateral vascularnetwork that begins developing at ¨E8.5. By late E10.5,
paired third, fourth, and sixth PAAs are patent, whereas the
first and second PAAs have already begun to regress and/or
transform. Asymmetric remodeling of the arch arteries
begins shortly after E10.5.
To examine early PAA development in detail, we
performed intracardiac India ink injections in Gbx2/ (n =
7) and wildtype (n = 9) embryos at E10.5 (Fig. 2). At E10.5,
defects in the development of both the left and right fourth
PAAs are evident in Gbx2 mutant embryos (Figs. 2C–H)
compared to controls (Figs. 2A–B). Gbx2 mutants display
the full spectrum of fourth PAA defects: absence (nonpatent
to ink) or hypoplasia of the left, right, or both fourth PAAs.
Table 1
Frequency of observed defects in various genotypes
Genotype n CV
defect
RAA IAA-B RE-RSA Other
CV
Non-CV
Gbx2+/+ 44 0 0 0 0 0 0
Gbx2+/ 72 0 0 0 0 0 0
Gbx2/ 49 19
(¨39%)
7 5 4 4a 0
Gbx2+/;
Fgf8+/
32 5
(¨16%*)
4 0 1 0 0
Gbx2/;
Fgf8+/
14 12
(¨86%*)
7 3 2 0 4b
CV—cardiovascular, RAA—right aortic arch, IAA-B—interrupted arch
type B, RE-RSA—retroesophogeal right subclavian artery.
a Double outlet right ventricle, overriding aorta.
b Abnormal thymus.
* P <0.01.
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Gbx2 mutants. In one case, we did observe a hypoplastic left
sixth PAA in association with a hypoplastic left fourth PAA
which would likely lead to the near-term observation of right
aortic arch with a right ductus arteriosus (Fig. 2F). These
observations are consistent with the developmental findings
near term and indicate that Gbx2 is predominantly required
for early development of the fourth PAAs.
To investigate the possibility that vessels are present but
nonpatent to ink in Gbx2 mutants, embryos were examined
in wholemount using laser confocal microscopy or embed-
ded in paraffin and sectioned for histological analysis (Fig.
3). In mutant embryos, whereas the third PAA forms
normally, the fourth PAA appears either hypoplastic (n =
5, Figs. 3B and D) or absent (n = 3, not shown) in
comparison to wildtype embryos (Figs. 3A and C).
To confirm proper segmentation of the pharyngeal
arches, we performed in situ hybridization analysis for
Pax1, which marks pharyngeal pouch endoderm in addition
to the somites (Deutsch et al., 1988). These results
demonstrate that initial pharyngeal arch segmentation
occurs normally in mutant embryos compared to wildtypes.
At E9.5 (n = 4, Figs. 3E and F) and E10.5 (n = 3, Fig. 3G
and H), Pax1 clearly demarcates the 1st, 2nd, and 3rd arches
in both mutants and wildtypes.
Neural crest patterning is abnormal in Gbx2/ embryos
Classic ablation studies in chick demonstrated the
importance of cardiac neural crest in septation of the outflow
tract, as well as for the proper development of the PAAs
(reviewed in Hutson and Kirby, 2003). Given the
observation that pharyngeal arch patterning appears
comparable between mutant and wildtype embryos, we
predicted that the loss of Gbx2 would lead to defects in
neural crest contribution to the caudal arches. To evaluate
the migration and patterning of cardiac neural crest cells
in mutant embryos, we performed wholemount mRNA in
situ hybridization for several markers of neural crest from
E9 to E10.5.Analysis of Crabp1 mRNA, which marks migrating
NCCs (Dencker et al., 1990), at E9–9.5 demonstrates a
marked reduction in migrating NCCs in 4 of 6 mutant
embryos analyzed compared to wildtype (n = 7). Most
notable is the reduction in post-otic NCCs entering caudal
pharyngeal arches (region of developing fourth PAAs) (Figs.
4B vs. 4A). Normal neural crest cell patterning in a subset of
mutants is consistent with the incomplete penetrance of the
PAA phenotype in near-term mutant embryos.
In addition to CrabP1, we examined AP2a protein
localization in Gbx2/ (n = 4) and control embryos (n =
4). At E10.5, the two distinct streams of NCCs migrate to the
caudal arches just posterior to the otocyst in normal embryos
(Fig. 4C). In contrast, mutant embryos display a neural crest
stream that is either the fusion of the two streams as one
discrete stream, or only one stream is present, which then
branches as the cells migrate ventrally (Fig. 4D). This
patterning defect is also seen in mutant embryos by in situ
hybridization for Sox10 (n = 4), whichmarks glial derivatives
at E10.5 (Pingault et al., 1998) (Figs. 4E and F). These results
suggest Gbx2 is necessary for proper patterning of the
migrating neural crest streams to the caudal arches.
Endothelial cells are disorganized in the fourth PAA in
Gbx2 mutants
NCCs can contribute to the development of the vascular
smooth muscle cell layer of the PAAs (Bergwerff et al.,
1998). To determine if Gbx2 mutant embryos were deficient
for smooth muscle cells around PAAs, we examined the
expression of a-smooth muscle actin (a-SMA) by section
immunohistochemistry.
We detected no differences in the level of smooth muscle
cell staining around the caudal PAAs in either E10.5 (n = 8)
or E11.5 (n = 5, not shown) Gbx2 mutant embryos when
compared to control embryos. Moreover, at E10.5, a-SMA
is only detectable in the third PAA and not in the fourth
PAA (Figs. 5A and B, white arrows). Because the defects in
the fourth PAA are already evident by E10.5 (yellow arrow
in B), this suggests Gbx2 is required for PAA development
prior to smooth muscle cell formation.
To investigate the possibility that the defect is in other
cell types, we looked at endothelial cell differentiation in
mutant pharyngeal arches. Immunohistochemistry for
PECAM on E10.5 sections of mutant and wildtype embryos
shows clear disorganization of endothelial cells in the
mutant fourth PAA (Figs. 5D and F) when compared to
the wildtype fourth PAA (Figs. 5C and E).
We next sought to determine if NCCs were under-
represented in the fourth pharyngeal arches of mutant
embryos. Co-labeling of PECAM-stained sections with
Ap2a revealed a deficiency in the number of Ap2a-positive
NCCs in the fourth pharyngeal arch in mutants compared to
wildtype embryos (arrowheads, Figs. 5C and D). This was
also apparent in wholemount (Figs. 4D vs. 4C, white
arrowheads).
Fig. 2. E10.5 ink injections demonstrate fourth PAA defects in Gbx2 mutants. Ink injections of control (A,B) and Gbx2/ (C–H) embryos. Both the right
(A,C,E,G) and left (B,D,F,H) arteries are shown for an individual embryo, respectively. At E10.5, all three pairs of caudal arch arteries are formed shown as R3,
R4, and R6 on the right and L3, L4, and L6 on the left in a wildtype (A and B, respectively). Panel C shows the lack of a right fourth arch (R4) artery whereas
the left side is grossly normal (D). Panel E shows hypoplasia of the right fourth (R4) and panel F shows left fourth (L4) and sixth (L6) arch artery hypoplasia in
a Gbx2 mutant. Panels G and H show bilateral absence of the fourth arch arteries (R4/L4).
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appear reduced in the caudal arches of Gbx2 mutants and
that they may play a role in the organization of endothelial
cells into tubes either directly or indirectly prior to the
differentiation of smooth muscle cells.
Other neural crest-related defects in Gbx2/ embryos
In addition to smooth muscle cells in the arches, NCCs
contribute greatly to craniofacial development (Chai et al.,2000). To determine if craniofacial skeletal structures are
abnormally patterned or formed due to the loss of Gbx2, we
examined bone preparations of E18.5 Gbx2 mutant and
wildtype littermates.
All Gbx2/ embryos examined (n = 5) demonstrated a
severely hypoplastic otic capsule compared to wildtype
embryos (n = 3) (Figs. 6A and B, Table 2). This is
consistent with the previously reported otic-related defects/
reduced otocyst (Wassarman et al., 1997) and with the
mRNA localization of Gbx2 in the dorsal region of the
Fig. 3. Pharyngeal arch patterning is normal while arterial defects are
present. Left lateral views of control (A,C,E,G) and Gbx2/ (B,D,F,H)
embryos. Confocal (A,B) and histological analysis (C,D) demonstrates that
segmented arches 3 and 4 are clearly demarcated by pouch endoderm at
E10.5 in both control and Gbx2 mutants. However, in both cases, the fourth
arch artery lumen appears hypoplastic or absent [AA4()] in the mutant. In
situ hybridization for Pax1 at E9.5 (E,F) and E10.5 (G,H) clearly defines
the pouch endoderm (arrowheads) in both the wildtype (E and G,
respectively) and mutant embryos (F and H, respectively). AA3 = 3rd
Arch artery, 1 = pharyngeal arch one, 2 = pharyngeal arch two.
Fig. 4. Neural crest patterning is affected by the loss of Gbx2. Left lateral
view of neural crest markers demonstrates abnormal patterning in Gbx2/
(B,D,F) mutants compared with controls (A,C,E). In situ hybridization for
CrabP1 demonstrates a reduction in post-otic migrating NCCs (white
bracket in panel B compared to the wildtype in panel A) to the caudal
pharyngeal arches at E9.5 in mutant embryos. Wholemount confocal
analysis for Ap2a antibody (Ab) at E10.5 shows two discrete streams of
migrating NCCs into arches 3–6 in wildtype embryos (C), whereas Gbx2
mutants exhibit abnormal patterning of these streams (D). The first stream
appears either truncated or fused with the second stream (arrow in panel D),
which splits to populate arches 3 to 6. Note apparent reduction in Ap2 a
antibody signal overlying developing fourth and sixth arches (arrowheads
in panel D vs. panel C). This abnormal pattern is also apparent by in situ
hybridization for Sox 10 at E10.5 (E,F). ot = Otocyst, numbers represent
respective arches.
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in the ectopic fusion of the incus and the styloid process
(arrowhead in Fig. 6B). In two cases (2 of 5), components of
the middle ear were severely hypoplastic, including the
incus and malleus, derivatives of the first pharyngeal arch,
and the styloid process and the stapes, derivatives of the
second arch (data not shown). Cartilages of the throat—
hyoid, thyroid, and cricoid, which are derived from the
second, third, and fourth/sixth arches, respectively, appear
unaffected in Gbx2 mutants (n = 5) (Figs. 6C and D). Cases
of cleft palate were infrequently observed in Gbx2/
embryos as well (not shown).The initial characterization of Gbx2 mutants demonstra-
ted defects in cranial nerve development, specifically the
absence of the trigeminal nerve (cranial nerve V) (Wassar-
man et al., 1997). However, this analysis did not extend to
the more caudal arches. To further investigate this prior
observation and determine if there were additional subtle
developmental or patterning defects in the neural crest-
dependent cranial nerves, we performed wholemount
immunohistochemistry for 2H3, a 155-kDa neurofilament
protein expressed specifically by cranial nerves and dorsal
root ganglia (Dodd et al., 1988).
We find the trigeminal ganglion is present in Gbx2
mutants (n = 4) on a C57Bl6 background; however, it is
shifted ventrally directly behind the eye compared to
wildtype embryos (n = 4). In addition, 3 of 4 Gbx2/
Fig. 5. Fourth PAA defects precede smooth muscle cell differentiation in Gbx2 mutants. Immunohistochemistry of sectioned wildtype (A,C,E) and Gbx2/
(B,D,F) PAAs. At E10.5, smooth muscle actin (a-SMA) is only detectable in third PAAs (not fourth PAAs) even though a fourth PAA lumen is present. No
difference in a-SMA staining is detected between wildtype and mutant (white arrows in A and B respectively). While the lumen of the fourth PAA is present in
Wt (asterisk—A), the presumptive artery is already defective in the mutant fourth pharyngeal arch (yellow arrow—B). Double labeling (C–F) for PECAM
(endothelial cells) and AP2a (Ectoderm and NCCs) demonstrates poorly organized endothelial cells (green) in mutants (D,F) compared to WT (C,E) as well as
a reduction in AP2a-positive NCCs about the arteries (red). White arrowheads in panels C and D point to comparable levels of NCCs invading the anterior
region of the third PAA in both wildtype and mutant and to the reduction of AP2a-positive NCCs in the mutant fourth PAA compared to wildtype. Arrowheads
in panel F point to endothelial cell disorganization in mutant compared to wildtype E. Panel E—higher magnification of panel C, panel F—higher
magnification of panel D. PAA = pharyngeal arch artery.
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glossopharyngeal and vagus nerves, respectively, just
posterior to the otocyst (Figs. 6F vs. 6E). Ectopic
connections between nerves are also apparent (note arrows
in Fig. 6F). This is likely a direct result of the aberrant
patterning of neural crest cell streams as seen by AP2a
immunohistochemistry and Sox 10 in situ hybridization
analysis (Figs. 4C–F).
Gbx2 is expressed in similar domains with Fgf8 in the
pharyngeal arches
The above defects demonstrate a role for Gbx2 in the
development of the fourth PAA as well as the patterning and
development of NCCs and their derivatives. These defects
are similar to those presented in Fgf8 mutants (Abu-Issa et
al., 2002; Frank et al., 2002).To identify the expression domains of Gbx2, we
performed in situ hybridization in wholemount and on
sections. Gbx2 mRNA is expressed in the pharyngeal arches
at E9.5 in a pattern similar to Fgf8 (arrowheads, Figs. 7A
and B). In particular, Gbx2 is robustly expressed overlying
the region of developing fourth PAAs (Fig. 7B).
To determine the extent of overlap with Fgf8 mRNA, we
performed in situ hybridization for both Gbx2 and Fgf8 on
adjacent cryosections (Figs. 7C and D). In situ hybridization
analysis shows that both Gbx2 and Fgf8 are expressed in the
ectoderm overlying developing fourth PAAs at E9.5 (black
arrowheads in Figs. 7C and D). Gbx2 is also expressed in
close proximity to Fgf8 in the endoderm of the third
pharyngeal arch and weakly expressed in the endoderm of
the fourth pharyngeal arch where Fgf8 is expressed (red
arrowheads), consistent with a model where the diffusible
ligand could induce Gbx2 in responsive tissues.
Fig. 6. Neural crest and cartilaginous defects. Bone preparations of E17.5 wildtype and mutant embryos demonstrate a severe reduction of the otic capsule (OC)
as well as the fusion of the styloid process (Sp) with the base of the incus (arrowheads in panel B compared to panel A). The formation of the neural crest-
derived elements of the middle ear, the malleus, stapes, and incus (M, St, I) were hypoplastic in mutants (2/5) compared to wildtype (data not shown). The
hyoid (H), cricoid (CT), and thyroid (T) cartilages of the throat appear comparable between wildtype and mutant (panels C and D, respectively). Wholemount
immunohistochemistry for the neurofilament marker 2H3 shows defective patterning of the cranial nerves at E10.5 in mutant embryos. In wildtype embryos
(E), the trigeminal (5), facial (7), glossopharyngeal (9), and vagus (10) nerves are all clearly separate. The loss of Gbx2 results in the fusion of the 9th and 10th
cranial nerves as well as ectopic projection between the trigeminal and the facial nerves (note arrowheads in panel F).
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PAA development
Due to the similar expression domains of Gbx2 and Fgf8
in the arches, we investigated a potential regulatory relation-
ship between the two genes during PAA development.
In situ hybridization for Fgf8 in Gbx2 mutant embryos at
E9.5 and E10.5 (not shown) did not reveal a change in the
level of Fgf8 mRNA expression in Gbx2 mutants (Fig. 7F)
compared to wildtype (Fig. 7E). Therefore, it is unlikely that
Fgf8 is downstream of or affected by the loss of Gbx2.
Studies show that ectopic FGF8 can induce Gbx2
expression. We performed in situ hybridization for Gbx2
in Fgf8neo/ (hypomorphic) embryos, previously reported to
have fourth PAA defects (Abu-Issa et al., 2002; Frank et al.,
2002) to determine if FGF8 is necessary for Gbx2
expression in the arches. The use of hypomorphic embryosTable 2
Craniofacial and cranial nerve defects in Gbx2/ embryos
Genotype Bone preps (¨E17.5) Cranial nerve analysis (E10.5)
n OC Hypoplastic
M, I, S
n 9/10 fusion EC
WT 3 0 0 4 0 0
Gbx2/ 5 5 (100%) 2 (40%) 4 3 (75%) 4 (100%)
OC = abnormal otic capsule, M—maleus, I—incus, S—stapes, 9/10—9,10
cranial nerve, EC—ectopic cranial nerve connections.is necessary due to the observation that Fgf8 null embryos
arrest at ¨E7.5 (Sun et al., 1999). In E9.5 Fgf8neo/ mutant
embryos, Gbx2 expression is reduced in the region over-
lying the future fourth PAAs in a subset of the mutants (4 of
10) compared to control littermates (Figs. 7G and H). Due to
the nature of the hypomorphic mutation, many embryos
likely express sufficient levels of Fgf8 to maintain normal
Gbx2 expression. While not definitive, this result is
consistent with previous reports and suggests that Fgf8
may lie upstream of Gbx2 in a regulatory pathway during
pharyngeal arch development, and that Fgf8 could poten-
tially exert some of its developmental effect through
regulation of Gbx2, in addition to other factors, in the
arches.
Lastly, we investigated whether loss of Gbx2 affected the
expression of Tbx1 . Like Fgf8, Tbx1 expression is
unaffected in Gbx2 mutants (Figs. 7J vs. 7I). This is
consistent with previous reports that Tbx1 lies upstream of
Fgf8 as evidenced by unaltered Tbx1 expression in Fgf8
hypomorphs (Abu-Issa et al., 2002) and loss of Fgf8 in
Tbx1 homozygous null embryos (Vitelli et al., 2002b).
Gbx2 and Fgf8 interact during development of the
pharyngeal arches
Given the observed reduction in Gbx2 expression over-
lying the developing fourth PAAs in Fgf8 mutants and the
Fig. 7. Gbx2 and Fgf8 expression and regulation in the pharyngeal arches. At ¨E9.5, in situ hybridization shows that both Fgf8 (A) and Gbx2 (B) are strongly
expressed in the caudal pharyngeal arches of wildtype embryos. White arrowheads in both show common/adjacent domains of expression. Note the particularly
robust Gbx2 expression overlying the fourth and developing sixth arch region in panel B. Adjacent section in situs for Fgf8 (C) and Gbx2 (D) show
overlapping domains of expression in the ectoderm (black arrowheads) overlying the third pharyngeal arch and developing fourth pharyngeal arch as well as in
the endoderm (red arrowheads). Wholemount in situ hybridization for Fgf8 in E9.5 WT (E) and Gbx2/ (F) embryos shows no consistent change in
expression in the pharyngeal arches. Analysis of Gbx2 mRNA expression in E9.5 Fgf8 hypomorphs (H) however, shows a reduction in the caudal arches
compared to WT (G—arrow). In situ hybridization for Tbx1 at E9.5 shown no overall change in expression between WT (I) and mutant embryos (J). Numbers
correspond to arches, Ot—otocyst.
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if a functional genetic relationship between Gbx2 and Fgf8
exists during pharyngeal arch and cardiovascular develop-
ment in mice. We crossed Gbx2+/;Fgf8+/ males with
Gbx2+/ females to generate Gbx2+/;Fgf8+/ and
Gbx2/;Fgf8+/ embryos for analysis.
We observed that ¨16% of Gbx2+/; Fgf8+/ embryos
(n = 5/32, P < 0.01) displayed defects in PAA remodeling
(see Table 1). RAA and RE-RSA were most commonly
observed. Conversely, no singly heterozygous animal
(Gbx2+/, n = 72 or Fgf8+/, n = 8 and n = 30 in
Vitelli et al., 2002b) was observed to have PAA remodel-
ing defects.
Gbx2/; Fgf8+/ embryos also exhibited a signifi-
cantly increased frequency, but not severity, of PAA-related
defects from 39% to 86% (n = 12/14, P < 0.01). In addition
to the PAA defects, approximately 29% (4/12) exhibited
abnormal development of the thymus appearing as either a
single-lobed thymus or reduced in overall size compared to
control littermates. No notable thymic defects were
observed in Gbx2/ or Fgf8+/ embryos but have been
reported for Fgf8neo/ embryos (Abu-Issa et al., 2002;
Frank et al., 2002). A few Gbx2/; Fgf8+/ embryos also
exhibited small external ears and a reduced mandible (seeTable 2). Early E9.5 in situ analysis of Gbx2/; Fgf8+/
embryos demonstrated a similar NCC migratory patterning
defect to Gbx2/ embryos (data not shown). These data
suggest that Gbx2 and Fgf8 interact genetically during
PAA development.Discussion
Our studies have revealed a novel role for the homeobox
gene Gbx2 in pharyngeal arch and cardiovascular develop-
ment in the mouse. Gbx2 mutants recapitulate some of the
phenotypes associated with 22q11 deletion syndromes
including PAA and craniofacial defects. Furthermore, we
have found that Gbx2 genetically interacts with Fgf8, a
putative modifier of the 22q11 deletion syndrome candidate
gene Tbx1.
Gbx2 and neural crest cells
Previous studies of Gbx2 have largely focused on its role
in the establishment of the mid–hindbrain organizer in
vertebrates and its interaction with several factors during
development (Joyner et al., 2000). These studies have led to
Fig. 8. Model for signaling hierarchy in the caudal pharyngeal arches. Our
results suggest that Fgf8 may act upstream of Gbx2 as well as through a
parallel pathway during pharyngeal arch development. Previous studies
demonstrated that Tbx1 lies upstream of Fgf8. Our data support Tbx1 as
being upstream of Gbx2.
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model organisms (mouse, chick, zebrafish) revealing a
noted, yet unstudied, domain of expression in the phar-
yngeal arches (Wassarman et al., 1997; Niss and Leutz,
1998; Shamim and Mason, 1998; Su and Meng, 2002;
Rhinn et al., 2003; Waters et al., 2003).
Our studies now reveal an important role for Gbx2 in the
development of the fourth PAA and proper patterning of
migrating NCCs into the pharyngeal arches. In the absence
of Gbx2, neural crest streams are abnormally patterned and
fuse just caudal to the otocyst leading to a decrease in
AP2a-positive NCCs populating the caudal arches. This
reduction in NCCs presumably results in the concomitant
PAA defects observed. Additionally, we observe defects in
cranial nerve patterning and hypoplastic development of
middle ear bones, both reliant on NCCs. Interestingly, we
observe incomplete penetrance of these defects, which we
hypothesize is likely due to a genetic background effect.
Genetic background has been reported to affect the
penetrance of the Tbx1 mutant phenotype (Jerome and
Papaioannou, 2001). Unlike Df1/+ mice, which harbor a
multigene mutation including Tbx1 and display a 22q11
deletion syndrome phenotype (Lindsay and Baldini, 2001),
our observations do not support the recovery of PAA defects
from E10.5 to term in Gbx2 mutants as an explanation for
reduced penetrance.
One possible explanation for the abnormal patterning of
NCCs is the anterior–posterior (A–P) deletion of neural
tissue corresponding to rhombomeres 1 through 3 in Gbx2
null embryos (Wassarman et al., 1997). It is possible that
the fusion and reduction of NCCs migrating to the
pharyngeal arches is the result of a local A–P patterning
defect. Alternatively, ectodermal and/or endodermal
expression domains of Gbx2 may be necessary in the
pharyngeal arch tissue itself to maintain a factor that
affects NCC development within the fourth pharyngeal
arches. What this factor might be remains unclear;
however, it is unlikely that this factor is FGF8, since the
expression of Fgf8 mRNA does not appear changed in the
arches of Gbx2 mutants.
NCCs are critical for the proper development of several
components derived from the pharyngeal arches, for
example, NCCs have been shown to contribute to the
smooth muscle cell layer about the developing arch arteries
(Bergwerff et al., 1998). Abnormal NCC migratory patterns
in the absence of Gbx2 suggested that the defects in PAA
development might be due to a deficiency of NCC-
dependent smooth muscle cell differentiation about the
arteries. We now show that NCCs might be necessary for
an even earlier developmental stage of the PAAs, such as
the organization of endothelial cells into tubules. Double
labeling of Gbx2 mutant PAAs identified disorganized
endothelial cells and a deficiency of NCCs in fourth PAAs.
These defects in the differentiation of fourth PAAs precede
detectable smooth muscle cell differentiation, eliminating
defects in this cell type as a causative agent. These findingsare in contrast to studies suggesting that NCCs are not
necessary for artery formation but for artery maintenance
(Waldo et al., 1996). Our data suggest that the NCCs may
be necessary for induction of arterial development and/or
assembly prior to differentiation of smooth muscle cells and
that Gbx2 is necessary for proper development of AP2a-
expressing NCCs around the fourth PAA. While we cannot
rule out a requirement for Gbx2 on endothelial cell
organization independent of NCCs, the striking reduction
in AP2a-expressing NCCs in the fourth pharyngeal arch
suggests a role for these cells in endothelial cell lumen
formation.
Gbx2 and Fgf8
Recent studies have identified Fgf8 as a critical signaling
factor in the development of pharyngeal arches and the
cardiovascular system in mice (Abu-Issa et al., 2002; Frank
et al., 2002; Macatee et al., 2003; Brown et al., 2004).
Similar to Gbx2 and Tbx1, Fgf8 is not expressed by NCCs
but is instead necessary for the survival of NCCs and
adjacent tissues (Trumpp et al., 1999; Frank et al., 2002).
We assayed for apoptosis in the pharyngeal arches of Gbx2
mutants but did not detect a change, suggesting different
cellular causes due to loss of Gbx2 or Fgf8 despite similar
phenotypes. We chose to address a potential interaction
between the two genes by analyzing trans heterozygotes as
well as the effect of Fgf8 dosage in Gbx2 null background.
The presence of PAA defects in Gbx2+/;Fgf8+/ mice and
not in Gbx2+/or Fgf8+/ mice alone provides evidence for
a genetic interaction between the two factors during
development. The overlap in mRNA expression of Gbx2
and Fgf8 at E9.5 suggests that this interaction may be
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pharyngeal arch and in the endoderm of the third pharyngeal
arch. Because the caudal PAAs are present by E10.5 during
normal development, we propose that the interaction
between Gbx2 and Fgf8 and subsequent effect on develop-
ment, is occurring at a slightly earlier stage. A recent study
has documented defects in fourth PAA development due to
tissue specific ablation of Fgf8 in the pharyngeal arch
ectoderm but not endoderm (Macatee et al., 2003; Brown et
al., 2004). While it is tempting to speculate that the Gbx2
domain in the ectoderm is similarly critical, the weak
expression of Gbx2 in the fourth pharyngeal arch endoderm
may also be important for proper PAA development. Future
tissue-specific ablation experiments of Gbx2 should deter-
mine if there are distinct ectodermal or endodermal roles
during this process.
We also determined that altering the dosage of Fgf8
in a Gbx2 null embryo significantly increases the
frequency of defects relative to Gbx2 mutation alone
(86% vs. 39%, respectively). Another interesting finding
in theGbx2/;Fgf8+/ embryos was the presence of thymic
defects in 29% of the mutants. Gbx2 mutants do not present
with thymic defects nor do Fgf8+/ mice. The thymus is
derived in part from the 3rd pouch endoderm and the
combined mutation of both genes in the endoderm likely
explains the presence of a defect in Gbx2/;Fgf8+/
embryos.
To explain the observed interaction between Gbx2 and
Fgf8, we propose a model (Fig. 8) where Fgf8 lies
upstream of Gbx2 in the arches, and acts partially through
Gbx2 regulation, as well as through a parallel pathway. We
propose a parallel pathway because altering the dose of
Fgf8 in a Gbx2 null embryo increases the frequency of PAA
defects. Therefore, Fgf8 cannot be acting solely through
Gbx2. In support of this hierarchy, our data show a
reduction of Gbx2 expression overlying the developing
fourth PAA in Fgf8 hypomorphic mutants. We observed no
change in expression of either Fgf8 or Tbx1 in the
pharyngeal arches of Gbx2 mutants placing Gbx2 down-
stream of these factors. Others have shown that Fgf8 is not
expressed in the endoderm of Tbx1/ embryos and that
Tbx1+/; Fgf8+/ embryos have an increased frequency of
PAA defects when compared to Tbx1+/ alone (Vitelli et al.,
2002b). In addition, TBX1 can activate an enhancer of Fgf8
during cardiac development (Hu et al., 2004), and tissue-
specific elimination of Fgf8 in Tbx1 domains results in
cardiovascular defects (Brown et al., 2004). These data
demonstrate that Fgf8 and Tbx1 interact genetically during
cardiovascular development. We now propose that Gbx2 is a
candidate downstream factor in this molecular pathway
during neural crest cell patterning and PAA development.
CHDs are the most common defect in newborn children
and fourth arch artery defects are highly associated with the
22q11 deletion in humans. The identification of a novel role
for Gbx2 in the pathogenesis of a 22q11 deletion syndrome-
like phenotype in mice and its interaction with a previouslyidentified modifier, Fgf8, make it a good candidate for
further analysis in determining the etiology of these
complex genetic syndromes. Future studies will be aimed
at determining the precise role of Gbx2 in neural crest
migration and colonization and searching for potential
downstream effectors during PAA development.Acknowledgments
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